Proceedings of the 3rd KOBI Congress, International and National Conferences (KOBICINC 2020)

In-Silico Studies of Antitumor Activity From Red Ginger (Alpinia purpurata Vieill) Bioactive Compounds

Authors
Santika Lusia Utami, Yogi Adhi Nugroho, Luthfiana Hardianingtyas, Fatiha Kamilah
Corresponding Author
Santika Lusia Utami
Available Online 23 June 2021.
DOI
10.2991/absr.k.210621.067How to use a DOI?
Keywords
AKT1, antitumor, docking, red ginger
Abstract

Many plants from the genus Alpinia are known to have several bioactive compounds that can act as an antitumor in cancer treatments. However, the potency of the bioactive compounds from red ginger as an antitumor agent has not been reported before. This research aims to study the inhibitory activity of several red ginger bioactive compounds against antitumor AKT1 protein through in-silico analysis. In this study, four identified bioactive compounds namely rutin, sitosteryl 3-O-6-palmytoil-β-d-glucoside, kumatakenin, kaempferol-3-o-glucuronide were used as a ligand for molecular interactions. The 3D structure of targetted protein AKT1 (PDB ID: 3O96) was obtained from the PDB database. [6]-shogaol, an antiproliferative and AKT1 inhibitor, was used as a control. In-silico docking analysis is performed in PyRx with the AutoDock Vina program. All bioactive compounds used in this experiment demonstrated good antitumor activity by binding to the inhibitor site of AKT1 protein. Rutin displayed the best potency as an inhibitor to AKT1 with the optimum binding energy of -11,3 kcal/mol as compared to control with -7,4 kcal/mol. These results suggest that bioactive compounds from red ginger may have the potency as an antitumor and can be developed to treat cancer.

Copyright
© 2021, the Authors. Published by Atlantis Press.
Open Access
This is an open access article distributed under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/).

Download article (PDF)

Volume Title
Proceedings of the 3rd KOBI Congress, International and National Conferences (KOBICINC 2020)
Series
Advances in Biological Sciences Research
Publication Date
23 June 2021
ISBN
978-94-6239-399-8
ISSN
2468-5747
DOI
10.2991/absr.k.210621.067How to use a DOI?
Copyright
© 2021, the Authors. Published by Atlantis Press.
Open Access
This is an open access article distributed under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/).

Cite this article

TY  - CONF
AU  - Santika Lusia Utami
AU  - Yogi Adhi Nugroho
AU  - Luthfiana Hardianingtyas
AU  - Fatiha Kamilah
PY  - 2021
DA  - 2021/06/23
TI  - In-Silico Studies of Antitumor Activity From Red Ginger (Alpinia purpurata Vieill) Bioactive Compounds
BT  - Proceedings of the 3rd KOBI Congress, International and National Conferences (KOBICINC 2020)
PB  - Atlantis Press
SP  - 395
EP  - 399
SN  - 2468-5747
UR  - https://doi.org/10.2991/absr.k.210621.067
DO  - 10.2991/absr.k.210621.067
ID  - Utami2021
ER  -